These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 21103389)

  • 21. Comparative modelling of cytochromes P450.
    Kirton SB; Baxter CA; Sutcliffe MJ
    Adv Drug Deliv Rev; 2002 Mar; 54(3):385-406. PubMed ID: 11922954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational solvent mapping reveals the importance of local conformational changes for broad substrate specificity in mammalian cytochromes P450.
    Clodfelter KH; Waxman DJ; Vajda S
    Biochemistry; 2006 Aug; 45(31):9393-407. PubMed ID: 16878974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystallization of cytochromes P450 and substrate-enzyme interactions.
    Li H; Poulos TL
    Curr Top Med Chem; 2004; 4(16):1789-802. PubMed ID: 15579108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108.
    de Groot MJ; Vermeulen NP; Kramer JD; van Acker FA; Donné-Op den Kelder GM
    Chem Res Toxicol; 1996; 9(7):1079-91. PubMed ID: 8902262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Structural Insights into Cytochrome P450 Function.
    Guengerich FP; Waterman MR; Egli M
    Trends Pharmacol Sci; 2016 Aug; 37(8):625-640. PubMed ID: 27267697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural diversity of eukaryotic membrane cytochrome p450s.
    Johnson EF; Stout CD
    J Biol Chem; 2013 Jun; 288(24):17082-90. PubMed ID: 23632020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
    Dong D; Wu B
    Drug Metab Rev; 2012 Feb; 44(1):1-17. PubMed ID: 22242930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural evidence: a single charged residue affects substrate binding in cytochrome P450 BM-3.
    Catalano J; Sadre-Bazzaz K; Amodeo GA; Tong L; McDermott A
    Biochemistry; 2013 Oct; 52(39):6807-15. PubMed ID: 23829560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformational states of cytochrome P450cam revealed by trapping of synthetic molecular wires.
    Hays AM; Dunn AR; Chiu R; Gray HB; Stout CD; Goodin DB
    J Mol Biol; 2004 Nov; 344(2):455-69. PubMed ID: 15522298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Theoretical investigation of substrate specificity for cytochromes P450 IA2, P450 IID6 and P450 IIIA4.
    De Rienzo F; Fanelli F; Menziani MC; De Benedetti PG
    J Comput Aided Mol Des; 2000 Jan; 14(1):93-116. PubMed ID: 10702928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P450BM-3; a tale of two domains--or is it three?
    Peterson JA; Sevrioukova I; Truan G; Graham-Lorence SE
    Steroids; 1997 Jan; 62(1):117-23. PubMed ID: 9029725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome P450 structure-function: insights from molecular dynamics simulations.
    Nair PC; McKinnon RA; Miners JO
    Drug Metab Rev; 2016 Aug; 48(3):434-52. PubMed ID: 27167388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computer modeling of 3D structures of cytochrome P450s.
    Chang YT; Stiffelman OB; Loew GH
    Biochimie; 1996; 78(8-9):771-9. PubMed ID: 9010606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular modeling of mammalian cytochrome P450s.
    Friedman FK; Robinson RC; Dai R
    Front Biosci; 2004 Sep; 9():2796-806. PubMed ID: 15353315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution.
    Yano JK; Wester MR; Schoch GA; Griffin KJ; Stout CD; Johnson EF
    J Biol Chem; 2004 Sep; 279(37):38091-4. PubMed ID: 15258162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular dynamics simulations of P450 BM3--examination of substrate-induced conformational change.
    Chang YT; Loew GH
    J Biomol Struct Dyn; 1999 Jun; 16(6):1189-203. PubMed ID: 10447203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of cytochrome p450s and personalized drug.
    Wang JF; Zhang CC; Chou KC; Wei DQ
    Curr Med Chem; 2009; 16(2):232-44. PubMed ID: 19149574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New findings in studies of cytochromes P450.
    Myasoedova KN
    Biochemistry (Mosc); 2008 Sep; 73(9):965-9. PubMed ID: 18976212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substrate recognition and molecular mechanism of fatty acid hydroxylation by cytochrome P450 from Bacillus subtilis. Crystallographic, spectroscopic, and mutational studies.
    Lee DS; Yamada A; Sugimoto H; Matsunaga I; Ogura H; Ichihara K; Adachi S; Park SY; Shiro Y
    J Biol Chem; 2003 Mar; 278(11):9761-7. PubMed ID: 12519760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.